Team

Strategic Advisors

Deborah Ancona, PhD
Seley Distinguished Professor of Management; Professor of Organization Studies; Faculty Director, MIT Leadership Center, MIT Sloan School of Management
Retsef Levi, PhD
J. Spencer Standish (1945) Professor of Management; Associate Professor of Operations Management, MIT Sloan School of Management
Denny A. Ausiello, MD
CATCH Co-Founder, Director; Jackson Professor of Clinical Medicine, Harvard Medical School; Chief of Medicine, MGH; Director, Pfizer
Andrew Lo, PhD
Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan School of Management
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Charles L. Cooney, PhD
Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation
Ram Sasisekharan, PhD
Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT
Michael A. Cusumano, PhD
Sloan Management Review Distinguished Professor of Management, MIT Sloan School of Management
Phillip A. Sharp, PhD
Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Elazer Edelman, MD, PhD, FACC
Thomas D & Virginia W Cabot Professor of HST, Health Sciences and Technology Program, MIT
Anthony Sinskey, ScD
Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT

Executive Advisory Network

The role of the Executive Advisory Network is to contribute ideas for projects, vet new opportunities, and disseminate emerging insights and recommendations from NEWDIGS activities. The Executive Advisory Network will assist with outreach to potential sponsors and endorse the goals of NEWDIGS projects as well the alignment of new projects with NEWDIGS mission and priorities; It has no financial or fiduciary responsibility, nor does it make any product-specific decisions. Typical agenda items include research updates, workshop opportunities, new mini-consortia proposals and pending publications.

Nick Crabb, PhD
Program Director, Scientific Affairs National Institute for Health & Clinical Excellence (NICE)
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Anne-Virginie Eggimann, MSc
Vice President, Regulatory Science bluebird bio
Peter Saltonsall
President and CEO National Organization for Rare Disorders (NORD)
Hans-Georg Eichler, MD, MSc
Senior Medical Officer European Medicines Agency
Harry Selker, MD, MSPH
Dean, Clinical and Translational Science Institute Institute for Clinical Research & Health Policy Studies Tufts University
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
David R. Strutton, PhD
Vice President of Global Pharmaceuticals and Policy Research, Center for Observational and Real-World Evidence, Merck & Co., Inc.
Hilary M. Malone, PhD
Chief Regulatory Officer, Head of Global Regulatory Affairs Sanofi
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting

Affiliated Faculty and Researchers

Jane F. Barlow, MD, MPH, MBA
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates
Kenneth A. Oye, PhD
Associate Professor of Political Science and Engineering Systems;; Co-Director, MIT Program on Emerging Technologies Massachusetts Institute of Technology
Ernest Berndt, PhD, MS
Louis E Seley Professor of Applied Economics, Sloan School of Management; Co-director Biomedical Enterprise Program
Nitin R. Patel, PhD
Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
Jeff Brown, PhD
Assistant Professor, Department of Population Medicine, Harvard Medical School
Casey Quinn, PhD
Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Chester Drum, MD, PhD
Assistant Professor, Department of Medicine, National University of Singapore
G.K. Raju, PhD
CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project
Judy Maro, PhD, MS
Research Affiliate, Center for Biomedical Innovation, Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting

NEWDIGS Staff

Matt W. Courtney, M.Ed
mcourtny@mit.edu
Communications Assistant, Financing and Reimbursement of Cures in the US (FoCUS)
617-715-5475
Eric A. Small
easmall@mit.edu
Administrative Assistant II, NEWDIGS; Assistant to Executive Director Gigi Hirsch
617-324-4841
David P. Fritsche, MBA
dpfritsc@mit.edu
Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Jonathan E. Thomas
jethomas@mit.edu
Research Technical Associate, Drug Development Pipeline Research, FoCUS
617-324-1726
Gigi Hirsch, M.D.
ghirsch@mit.edu
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Katie Torrence
ktorrenc@mit.edu
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-2695
Kay Larholt, ScD
klarholt@mit.edu
Director of Integrated Knowledge Solutions
617-253-7333
Mark Trusheim, MSc
trusheim@mit.edu
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Daniel Mytelka, PhD, MBA, CFA
mytelka@mit.edu
Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS)
Deborah L. Young, EMBA, Ed.M.
debyoung@mit.edu
Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
617-324-7756
Kelly Necastro, MPH
kneca@mit.edu
Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Colin Young, PhD
colyoung@mit.edu
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-7261

FoCUS Project Team

Financing and Reimbursement of Cures in the U.S.

Jane F. Barlow, MD, MPH, MBA
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project; CEO, Jane Barlow & Associates
J. Russell Teagarden, DMH, MA
Senior Health Care Practitioner, Independent Advisor, Researcher and Writer; Financing and Reimbursement of Cures in the US (FoCUS) Project
Matt W. Courtney, M.Ed
Communications Assistant, Financing and Reimbursement of Cures in the US (FoCUS)
617-715-5475
Jonathan E. Thomas
Research Technical Associate, Drug Development Pipeline Research, FoCUS
617-324-1726
R. John Glasspool
Senior Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Katie Torrence
Project Coordinator, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-2695
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Daniel Mytelka, PhD, MBA, CFA
Director, Simulation & Policy Research, Financing and Reimbursement of Cures in the US (FoCUS)
Colin Young, PhD
Director, Drug Development Pipeline Research, Financing and Reimbursement of Cures in the US (FoCUS)
617-324-7261
Casey Quinn, PhD
Research Advisor, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
Deborah L. Young, EMBA, Ed.M.
Director of Operations, MIT Center for Biomedical Innovation: NEWDIGS; Financing and Reimbursement of Cures in the US (FoCUS) Project
617-324-7756
Jonathan Salcedo
USC/NEWDIGS Research Fellow, FoCUS Project

LEAPS Project Team

David P. Fritsche, MBA
Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Kelly Necastro, MPH
Project Coordinator, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project
617-324-7763
Gigi Hirsch, M.D.
Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology; Director NEWDIGS
617-253-9609
Mark Trusheim, MSc
Strategic Director, NEWDIGS; Visiting Scientist, Sloan School of Management Massachusetts Institute of Technology; President, Co-Bio Consulting
Kay Larholt, ScD
Director of Integrated Knowledge Solutions
617-253-7333

Strategic Advisory Network

Anna D. Barker, PhD
Co-Director, Complex Adaptive Systems (CAS); Director, National Biomarker Development Alliance (NBDA); Professor, School of Life Sciences, Arizona State University (ASU)
Secretary Marylou Sudders, MS, Hon.DSc
Secretary of Health and Human Services, Commonwealth of Massachusetts
Alex 'Sandy' Pentland, PhD
Professor of Media Arts and Sciences, Toshiba Professor, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Peter Szolovits, PhD
Professor, Department of Electrical Engineering and Computer Science (EECS), Institute for Medical Engineering and Science (IMES), Massachusetts Institute of Technology
Richard Platt, MD, MSc
Executive Director, Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School
Susan Windham-Bannister, PhD
President & CEO, Biomedical Growth Strategies LLC; Managing Partner, Biomedical Innovation Advisors LLC
Michael S. Sherman, MD, MBA, MS, CPE
Senior Vice President & Chief Medical Officer; Harvard Pilgrim Health Care
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research, US Food and Drug Administration